A strategy for determining MRD in AML that has been advocated is:
A) Panel: CD38, CD138 and CD45
B) Panel: CD20/CD38/CD19/CD5
C) "Different than normal"
D) Boolean gating

Question

Quizplus · Accepted Answer

The strategy for determining MRD in AML that has been advocated is "different than normal". This involves identifying abnormal populations of cells using flow cytometry, which may include aberrant expression of antigen markers or shifts in antigen intensity compared to normal cells. This approach allows for early detection of residual disease and monitoring of treatment response, without relying on a specific panel of markers that may not be universally applicable.

A Strategy for Determining MRD in AML That Has Been